Immunization
Enumeration VaccinationContraindication

Enumeration Literals
161461006 (history of purpura) 161461006 (history of purpura)
27624003 (chronic disease) 27624003 (chronic disease)
294466005 (allergy to streptomycin) 294466005 (allergy to streptomycin)
294468006 (allergy to neomycin) 294468006 (allergy to neomycin)
294530006 (allergy to Polymyxin B) 294530006 (allergy to Polymyxin B)
294847001 (allergy to gelatin) 294847001 (allergy to gelatin)
300916003 (allergy to latex) 300916003 (allergy to latex)
302215000 (thrombocytopenic disorder) 302215000 (thrombocytopenic disorder)
402306009 (allergy to aluminum) 402306009 (allergy to aluminum)
77386006 (currently pregnant) 77386006 (currently pregnant)
91930004 (allergy to eggs) 91930004 (allergy to eggs)
VXC17 (allergy to 2-phenoxyethanol) VXC17 (allergy to 2-phenoxyethanol)
VXC18 (allergy to baker’s yeast) VXC18 (allergy to baker’s yeast)
VXC19 (allergy to thimerosal) VXC19 (allergy to thimerosal)
VXC20 (allergy to previous dose of this vaccine...) VXC20 (allergy to previous dose of this vaccine...)
VXC21 (previous history of intussusception) VXC21 (previous history of intussusception)
VXC22 (encephalopathy w/in 7 days of DTP or DTaP...) VXC22 (encephalopathy w/in 7 days of DTP or DTaP...)
VXC23 (current fever) VXC23 (current fever)
VXC24 (current acute illness) VXC24 (current acute illness)
VXC25 (history of Arthus hypersensitivity...) VXC25 (history of Arthus hypersensitivity...)
VXC26 (underlying unstable neurologic disorders...) VXC26 (underlying unstable neurologic disorders...)
VXC27 (immunodeficiency) VXC27 (immunodeficiency)
VXC30 (allergy to rodent or neural protein) VXC30 (allergy to rodent or neural protein)

Properties:

Alias
Is Abstractfalse
Is Leaffalse
Keywords
NameVaccinationContraindication
Name Expression
NamespaceImmunization
Owned Template Signature
OwnerImmunization
Owning Template Parameter
PackageImmunization
Qualified NameFHIM::Immunization::VaccinationContraindication
Representation
Stereotype
Template Parameter
VisibilityPublic

Comments